{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:17:53Z","timestamp":1781223473413,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,16]]},"DOI":"10.7759\/cureus.47135","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T17:07:47Z","timestamp":1697476067000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case Report of Treatment With Cariprazine in a Recurrent Psychosis Presumably Induced by Methamphetamine"],"prefix":"10.7759","author":[{"given":"Robert A","family":"Moran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cydne","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una","family":"Della-Pietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Jacome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000767","article-title":"Methamphetamine dysregulation of the central nervous system and peripheral immunity","volume":"379","author":"Miller DR","year":"2021","unstructured":"Miller DR, Bu M, Gopinath A, Martinez LR, Khoshbouei H. Methamphetamine dysregulation of the central nervous system and peripheral immunity. J Pharmacol Exp Ther. 2021, 379:372-85. 10.1124\/jpet.121.000767","journal-title":"J Pharmacol Exp Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank CC","year":"2009","unstructured":"Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009, 104:1085-99. 10.1111\/j.1360-0443.2009.02564.x","journal-title":"Addiction"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00491","article-title":"A comparison of methamphetamine induced psychosis and schizophrenia: a review of positive, negative and cognitive symptomatology","volume":"9","author":"Wearne TA","year":"2018","unstructured":"Wearne TA, Cornish JL. A comparison of methamphetamine induced psychosis and schizophrenia: a review of positive, negative and cognitive symptomatology. Front Psychiatry. 2018, 9:491. 10.3389\/fpsyt.2018.00491","journal-title":"Front Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2021.1945398","article-title":"Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report","volume":"40","author":"Ricci V","year":"2022","unstructured":"Ricci V, Di Salvo G, Maina G. Remission of persistent methamphetamine-induced psychosis after cariprazine therapy: presentation of a case report. J Addict Dis. 2022, 40:145-8. 10.1080\/10550887.2021.1945398","journal-title":"J Addict Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0209-8","article-title":"Methamphetamine psychosis: epidemiology and management","volume":"28","author":"Glasner-Edwards S","year":"2014","unstructured":"Glasner-Edwards S, Mooney LJ. Methamphetamine psychosis: epidemiology and management. CNS Drugs. 2014, 28:1115-26. 10.1007\/s40263-014-0209-8","journal-title":"CNS Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103259","article-title":"Common gray matter loss in the frontal cortex in patients with methamphetamine-associated psychosis and schizophrenia","volume":"36","author":"Jia X","year":"2022","unstructured":"Jia X, Wang J, Jiang W, et al.. Common gray matter loss in the frontal cortex in patients with methamphetamine-associated psychosis and schizophrenia. Neuroimage Clin. 2022, 36:103259. 10.1016\/j.nicl.2022.103259","journal-title":"Neuroimage Clin"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13241","article-title":"Case series: cariprazine for treatment of methamphetamine use disorder","volume":"31","author":"Truong TT","year":"2022","unstructured":"Truong TT, Li B. Case series: cariprazine for treatment of methamphetamine use disorder. Am J Addict. 2022, 31:85-8. 10.1111\/ajad.13241","journal-title":"Am J Addict"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.727666","article-title":"Case report: cariprazine in a patient with schizophrenia, substance abuse, and cognitive dysfunction","volume":"12","author":"Rodriguez Cruz J","year":"2021","unstructured":"Rodriguez Cruz J, Sahlsten Sch\u00f6lin J, Hjorth S. Case report: cariprazine in a patient with schizophrenia, substance abuse, and cognitive dysfunction. Front Psychiatry. 2021, 12:727666. 10.3389\/fpsyt.2021.727666","journal-title":"Front Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S355941","article-title":"Cariprazine on psychosis: beyond schizophrenia - a case series","volume":"18","author":"Bajouco M","year":"2022","unstructured":"Bajouco M, Mota D. Cariprazine on psychosis: beyond schizophrenia - a case series. Neuropsychiatr Dis Treat. 2022, 18:1351-62. 10.2147\/NDT.S355941","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2016.01.010","article-title":"Fronto-temporal alterations and affect regulation in methamphetamine dependence with and without a history of psychosis","volume":"248","author":"Uhlmann A","year":"2016","unstructured":"Uhlmann A, Fouche JP, Koen N, Meintjes EM, Wilson D, Stein DJ. Fronto-temporal alterations and affect regulation in methamphetamine dependence with and without a history of psychosis. Psychiatry Res Neuroimaging. 2016, 248:30-8. 10.1016\/j.pscychresns.2016.01.010","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.04.029","article-title":"Volume reductions in frontopolar and left perisylvian cortices in methamphetamine induced psychosis","volume":"147","author":"Aoki Y","year":"2013","unstructured":"Aoki Y, Orikabe L, Takayanagi Y, et al.. Volume reductions in frontopolar and left perisylvian cortices in methamphetamine induced psychosis. Schizophr Res. 2013, 147:355-61. 10.1016\/j.schres.2013.04.029","journal-title":"Schizophr Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113795","article-title":"Neurotoxicity of methamphetamine: main effects and mechanisms","volume":"344","author":"Jayanthi S","year":"2021","unstructured":"Jayanthi S, Daiwile AP, Cadet JL. Neurotoxicity of methamphetamine: main effects and mechanisms. Exp Neurol. 2021, 344:113795. 10.1016\/j.expneurol.2021.113795","journal-title":"Exp Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00551","article-title":"A research of methamphetamine induced psychosis in 1,430 individuals with methamphetamine use disorder: clinical features and possible risk factors","volume":"9","author":"Gan H","year":"2018","unstructured":"Gan H, Zhao Y, Jiang H, et al.. A research of methamphetamine induced psychosis in 1,430 individuals with methamphetamine use disorder: clinical features and possible risk factors. Front Psychiatry. 2018, 9:551. 10.3389\/fpsyt.2018.00551","journal-title":"Front Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.01.018","article-title":"The profile of psychiatric symptoms exacerbated by methamphetamine use","volume":"161","author":"McKetin R","year":"2016","unstructured":"McKetin R, Dawe S, Burns RA, et al.. The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend. 2016, 161:104-9. 10.1016\/j.drugalcdep.2016.01.018","journal-title":"Drug Alcohol Depend"},{"key":"ref15","unstructured":"Is the PANSS  being used properly?. (2011). https.\/\/www.hcplive.com\/view\/is-the-panss-being-used-properly-."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.816339","article-title":"What is the minimum clinically important change in negative symptoms of schizophrenia? PANSS based post-hoc analyses of a phase III clinical trial","volume":"13","author":"Czobor P","year":"2022","unstructured":"Czobor P, Sebe B, Acsai K, et al.. What is the minimum clinically important change in negative symptoms of schizophrenia? PANSS based post-hoc analyses of a phase III clinical trial. Front Psychiatry. 2022, 13:816339. 10.3389\/fpsyt.2022.816339","journal-title":"Front Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.chiabu.2020.104819","article-title":"Mental health disorders as cooccuring and predictive factors of psychotic disorders in sexually abused children","volume":"111","author":"Bourgeois C","year":"2021","unstructured":"Bourgeois C, Lecomte T, McDuff P, Daigneault I. Mental health disorders as cooccuring and predictive factors of psychotic disorders in sexually abused children. Child Abuse Negl. 2021, 111:104819. 10.1016\/j.chiabu.2020.104819","journal-title":"Child Abuse Negl"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.06.042","article-title":"Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis","volume":"142","author":"Ding Y","year":"2014","unstructured":"Ding Y, Lin H, Zhou L, Yan H, He N. Adverse childhood experiences and interaction with methamphetamine use frequency in the risk of methamphetamine-associated psychosis. Drug Alcohol Depend. 2014, 142:295-300. 10.1016\/j.drugalcdep.2014.06.042","journal-title":"Drug Alcohol Depend"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-011-9288-1","article-title":"Methamphetamine-associated psychosis","volume":"7","author":"Grant KM","year":"2012","unstructured":"Grant KM, LeVan TD, Wells SM, et al.. Methamphetamine-associated psychosis. J Neuroimmune Pharmacol. 2012, 7:113-39. 10.1007\/s11481-011-9288-1","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/174997-a-case-report-of-treatment-with-cariprazine-in-a-recurrent-psychosis-presumably-induced-by-methamphetamine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:34Z","timestamp":1707509134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/174997-a-case-report-of-treatment-with-cariprazine-in-a-recurrent-psychosis-presumably-induced-by-methamphetamine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.47135","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,16]]}}}